news
Pathogens exert physical force to avoid ingestion within phagocytes
A previously unknown process by which pathogens breach immune defences offers promise for treating infectious diseases.
List view / Grid view
Tuberculosis
news
Specialised white blood cells could lead to more preventative treatments
Australian researchers analyse the way specialised white blood cells produce an immune response, which could lead to the development of preventative treatments for cancer and infectious diseases.
news
The immune system’s power over antibiotics for infections
The natural process of removing damaged cell parts could present an alternative to antibiotics, especially where bacteria have become resistant to existing drugs.
news
Research highlights interaction of mycobacteria with red blood cells and its role in lung disease
A new study has found that mycobacteria are associated with red blood cells at lung infection sites, an interaction that has escaped scientists for 140 years.
news
Possible connection between HIV and tuberculosis revealed
A recent study has shown that antiretroviral therapy timing impacts the animal version of HIV and latent tuberculosis.
news
Scientists develop novel strategy for tuberculosis vaccine
A research team have created a new strategy for developing an effective vaccine against a widespread form of tuberculosis.
news
New method for rapid development of vaccines for pre-clinical tests
Using synthetic chemistry, researchers have fused hydrophobic adjuvants with water-soluble proteins to create a new type of vaccine.
article
The latest pre-clinical HIV vaccine developments
This article lists three of the most recent advances in pre-clinical HIV research and vaccine development.
news
Two compounds exhibit antibacterial properties against tuberculosis
Tested on two assays, researchers have shown that Redx03863 and Redx04739 can combat tuberculosis and do not lead to resistance.
news
Imaging and machine learning system created to discover tuberculosis drugs
Researchers have developed MorphEUS, a technology to identify new drugs that combat M. tuberculosis by revealing how compounds destroy the bacteria.
news
£280 million donated for COVID-19 research in three months
A study has shown that the COVID-19 pandemic has resulted in a high level of research donations, making the condition the third most funded disease on average by year.
news
Novel technique reveals how TB antibiotics reach their targets
Researchers have used a new method to understand how antibiotics fight TB, which can guide future drug developments.
news
Boosting immune cells could provide TB treatment
A new study has identified a class of immune cells that respond to tuberculosis, indicating a drug target for the condition.
news
Immune cells could be key to tuberculosis treatment, study finds
Researchers have found that certain immune cells aid in fighting tuberculosis bacteria, providing a new drug target.
news
Antibiotics developed in 1960s show promise for Tuberculosis therapy
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Tuberculosis is the most deadly infectious disease in the world. Standard TB therapy takes at least 6 months and patients infected with multi-drug...